Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps (Q37972359)

26 August 2017

title

Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps (English)

1 reference

26 August 2017

0 references

1 reference

2

P. Darmon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22208717

21 December 2024

author name string

P. Schaepelynck

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22208717

21 December 2024

L. Molines

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22208717

21 December 2024

M. F. Jannot-Lamotte

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22208717

21 December 2024

C. Treglia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22208717

21 December 2024

D. Raccah

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22208717

21 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22208717

21 December 2024

publication date

1 December 2011

1 reference

26 August 2017

December 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22208717

full work available at URL

21 December 2024

https://api.elsevier.com/content/article/PII:S1262363611709727?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

https://api.elsevier.com/content/article/PII:S1262363611709727?httpAccept=text/plain

21 December 2024

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

21 December 2024

published in

Diabetes and Metabolism

1 reference

26 August 2017

volume

37 Suppl 4

1 reference

26 August 2017

page(s)

S85-93

1 reference

Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Patch-pump technology to manage type 2 diabetes mellitus: hurdles to market acceptance

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Evolution of diabetes insulin delivery devices

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Insulin patch pumps: their development and future in closed-loop systems

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

OmniPod Insulin Management System: patient perceptions, preference, and glycemic control

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

A prospective trial of U500 insulin delivered by Omnipod in patients with type 2 diabetes mellitus and severe insulin resistance

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Pascal's wager: combining continuous glucose monitoring and continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

The SWITCH Study (Sensing With Insulin pump Therapy to Control HbA1c): Design and Methods of a Randomized Controlled Crossover Trial on Sensor-Augmented Insulin Pump Efficacy in Type 1 Diabetes Suboptimally Controlled with Pump Therapy

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Continuous glucose monitoring and intensive treatment of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: a prospective 6-month study

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Response to nocturnal alarms using a real-time glucose sensor

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM.

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Real-Time hypoglycemia prediction suite using continuous glucose monitoring: a safety net for the artificial pancreas

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Accuracy of a new real-time continuous glucose monitoring algorithm

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Prevention of Hypoglycemia by Using Low Glucose Suspend Function in Sensor-Augmented Pump Therapy

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Semi-Closed-Loop Insulin Delivery Systems: Early Experience with Low-Glucose Insulin Suspend Pumps

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Intraperitoneal insulin administration produces a positive portal-systemic blood insulin gradient in unanesthetized, unrestrained swine

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

The kinetics of peritoneal insulin absorption

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Normalization of plasma insulin profiles with intraperitoneal insulin infusion in diabetic man

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

A preliminary trial of the programmable implantable medication system for insulin delivery

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Clinical trial of programmable implantable insulin pump for type I diabetes

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

French multicentre experience of implantable insulin pumps. The EVADIAC Study Group. Evaluation of Active Implants in Diabetes Society

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabète du Traitement par Implants Actifs

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Decreased severe hypoglycemia frequency during intraperitoneal insulin infusion using programmable implantable pumps. Evadiac Study Group

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

A Recent Survey Confirms the Efficacy and the Safety of Implanted Insulin Pumps During Long-Term Use in Poorly Controlled Type 1 Diabetes Patients

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Continuous intraperitoneal insulin infusion in patients with 'brittle' diabetes: favourable effects on glycaemic control and hospital stay.

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Randomized Comparison of Metabolic Control Achieved by Intraperitoneal Insulin Infusion With Implantable Pumps Versus Intensive Subcutaneous Insulin Therapy in Type I Diabetic Patients

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

A cost-benefit comparison of intensive diabetes management with implantable pumps versus multiple subcutaneous injections in patients with type I diabetes.

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Local adverse events associated with long-term treatment by implantable insulin pumps. The French EVADIAC Study Group experience. Evaluation dans le Diabète du Traitement par Implants Actifs

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Insulin antibody responses after long-term intraperitoneal insulin administration via implantable programmable insulin delivery systems.

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Immunogenicity of intraperitoneal insulin infusion using programmable implantable devices

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Immunogenicity of long-term intraperitoneal insulin administration with implantable programmable pumps. Metabolic consequences

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Macrophage activation in type 1 diabetic patients with catheter obstruction during peritoneal insulin delivery with an implantable pump

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Comparison of antigenicity of Hoechst 21PH insulin using either implantable intraperitoneal pump or subcutaneous external pump infusion in type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

The implantable peritoneal pump--a patient's perspective

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Implantable insulin pumps. A position statement about their clinical use.

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system.

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

7 January 2021

Variation of insulin absorption during subcutaneous and peritoneal infusion in insulin-dependent diabetic patients with unsatisfactory long-term glycaemic response to continuous subcutaneous insulin infusion

28

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

Reproducibility of plasma insulin kinetics during intraperitoneal insulin treatment by programmable pumps

21 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients

21 December 2024

34

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(11)70972-7

21 December 2024

Identifiers

1 reference

26 August 2017

1 reference